Results 111 to 120 of about 14,252 (249)

Software Mitigation of RISC-V Spectre Attacks

open access: yes
Speculative attacks are still an active threat today that, even if initially focused on the x86 platform, reach across all modern hardware architectures. RISC-V is a newly proposed open instruction set architecture that has seen traction from both the industry and academia in recent years. In this paper we focus on the RISC-V cores where speculation is
Ruxandra Balucea, Paul Irofti
openaire   +2 more sources

Counter‐ion modulation: A facile approach toward quenching‐resistant multi‐resonance emitters for efficient narrowband electroluminescence

open access: yesFlexMat, EarlyView.
Quenching‐resistant carbocation‐based multi‐resonance emitters are developed via a facile counter‐ion modulation strategy, giving much narrowed emission bands under high doping concentrations, and greatly improved device efficiency for solution‐processed narrowband OLEDs by simply increasing the size of counter ions.
Tao Li   +9 more
wiley   +1 more source

Recent advances and prospects for high‐efficiency blue hot exciton organic light‐emitting diodes

open access: yesFlexMat, EarlyView.
Blue organic light‐emitting diodes (OLEDs) face great challenges in achieving the balance between color purity, device efficiency, and stability. Hot exciton materials offer a solution by rapidly converting non‐emissive triplet excitons into singlet ones through a high‐lying reverse intersystem crossing process.
Xiaoen Shi   +3 more
wiley   +1 more source

The Rise and Popularity of RISC-V

open access: yes
RISC-V, a Reduced Instruction Set Computer (RISC) architecture has emerged as the architecture of choice for power-conscious devices such as tablets, mobile phones, and IoT embedded systems. This article looks at the evolution of RISC-V to give readers a historical perspective on its enormous success.
Saroj Rout, Chandra Shekhar
openaire   +1 more source

Epigenetic Dysregulation of Somatostatin Receptors (SSTR) 1–5 and Therapeutic Implications in Neuroendocrine and Non‐Neuroendocrine Malignancies

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Somatostatin receptors (SSTR) mediate the antiproliferative, antisecretory, and proapoptotic effects of somatostatin and its synthetic analogs. Their surface expression on neuroendocrine tumor (NET) cells is required for somatostatin analog therapy and radiopharmaceutical therapy (RPT).
Neeraj Kumari   +10 more
wiley   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

open access: yesiNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong   +5 more
wiley   +1 more source

Feasibility of an Online Resilience Program for Mothers With Adverse Childhood Experiences

open access: yesResearch in Nursing &Health, EarlyView.
ABSTRACT Enhancing maternal resilience through targeted interventions has emerged as a promising strategy for preventing the intergenerational transmission of adverse childhood experiences (ACEs). This study aimed to develop and evaluate the feasibility of an online resilience program tailored for mothers with ACEs.
Hyeseon Yun, Eun Kyoung Choi
wiley   +1 more source

RNA degradomics and proteomics reveal the mechanism of dsProsβ1‐mediated proteasome targeting in Psylliodes chrysocephala

open access: yesPest Management Science, EarlyView.
RNA degradomics revealed dsProsβ1‐derived siRNA‐mediated mRNA cleavage events, mainly at uracil‐guanine and adenine‐adenine pairs. Proteasome inhibition via dsProsβ1 increased mitochondrial and cytoskeletal proteins while reducing translation‐related and mRNA‐binding proteins.
Doga Cedden   +3 more
wiley   +1 more source

Dose‐dependent efficacy of a novel dsRNA‐based solution containing vadescana for Varroa destructor control

open access: yesPest Management Science, EarlyView.
Vadescana is a novel dsRNA‐based product that targets Varroa fecundity. Vadescana applied at 4 g/brood box in one application was most effective at reducing Varroa populations for up to 18 weeks. Abstract BACKGROUND A novel dsRNA‐based product, containing a molecule called vadescana, interferes with Varroa destructor (Anderson and Trueman) fecundity ...
Briana E Price   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy